[PDF] sciencedirect.com

Circulating tumor cell–based molecular classifier for predicting resistance to abiraterone and enzalutamide in metastatic castration-resistant prostate cancer

JS Chung, Y Wang, J Henderson, U Singhal, Y Qiao… - Neoplasia, 2019 - Elsevier
While circulating tumor cell (CTC)–based detection of AR-V7 has been demonstrated to
predict patient response to second-generation androgen receptor therapies, the rarity of AR …
被引用次数：34 相关文章 所有 5 个版本

AR‐V7 in circulating tumor cells cluster as a predictive biomarker of abiraterone acetate and enzalutamide treatment in castration‐resistant prostate cancer patients

T Okegawa, N Ninomiya, K Masuda, Y Nakamura… - The …, 2018 - Wiley Online Library
Objective We examined whether androgen receptor splice variant 7 (AR‐V7) in circulating
tumor cell (CTC) clusters can be used to predict survival in patients with bone metastatic …
被引用次数：60 相关文章 所有 5 个版本
[PDF] ascopubs.org

Prospective multicenter study of circulating tumor cell AR-V7 and taxane versus hormonal treatment outcomes in metastatic castration-resistant prostate cancer

AJ Armstrong, J Luo, DM Nanus… - JCO precision …, 2020 - ascopubs.org
PURPOSE Androgen receptor splice variant 7 (AR-V7) detection in circulating tumor cells
(CTCs) is associated with a low probability of response and short progression-free (PFS) …
被引用次数：56 相关文章 所有 8 个版本
[HTML] sciencedirect.com

[HTML][HTML] Nuclear-specific AR-V7 protein localization is necessary to guide treatment selection in metastatic castration-resistant prostate cancer

HI Scher, RP Graf, NA Schreiber, B McLaughlin, D Lu… - European urology, 2017 - Elsevier
Abstract Background Circulating tumor cells (CTCs) expressing AR-V7 protein localized to
the nucleus (nuclear-specific) identify metastatic castration-resistant prostate cancer …
被引用次数：176 相关文章 所有 10 个版本
[PDF] nature.com

Comparison of circulating tumor cells and AR-V7 as clinical biomarker in metastatic castration-resistant prostate cancer patients

K Schlack, K Seitzer, N Wüstmann, V Humberg… - Scientific Reports, 2022 - nature.com
Biomarker in metastatic castration resistant prostate cancer (mCRPC) treatment are rare. We
aimed to compare the clinical value of circulating tumor cells (CTCs) and androgen receptor …
被引用次数：5 相关文章 所有 12 个版本
[PDF] mdpi.com

Analysis of AR/ARV7 expression in isolated circulating tumor cells of patients with metastatic castration-resistant prostate cancer (SAKK 08/14 IMPROVE Trial)

I Bratic Hench, R Cathomas, L Costa, N Fischer… - Cancers, 2019 - mdpi.com
Despite several treatment options and an initial high response rate to androgen deprivation
therapy, the majority of prostate cancers will eventually become castration-resistant in the …
被引用次数：19 相关文章 所有 12 个版本
[HTML] nih.gov

Clinical significance of androgen receptor splice variant-7 mRNA detection in circulating tumor cells of men with metastatic castration-resistant prostate cancer treated …

ES Antonarakis, C Lu, B Luber, H Wang… - Journal of Clinical …, 2017 - ascopubs.org
Purpose We reported previously that the detection of androgen receptor splice variant-7 (AR-
V7) mRNA in circulating tumor cells (CTCs) correlated with poor outcomes from the use of …
被引用次数：445 相关文章 所有 8 个版本
[HTML] sciencedirect.com

[HTML][HTML] CABA-V7: a prospective biomarker selected trial of cabazitaxel treatment in AR-V7 positive prostate cancer patients

KT Isebia, B Mostert, BPS Belderbos, SAJ Buck… - European Journal of …, 2022 - Elsevier
Background Metastatic castration-resistant prostate cancer (mCRPC) patients with positive
AR-V7 expression in their circulating tumour cells (CTCs) rarely derive benefit from …
被引用次数：9 相关文章 所有 4 个版本
[PDF] bietenbeck.net

AR-V7 in peripheral whole blood of patients with castration-resistant prostate cancer: association with treatment-specific outcome under abiraterone and enzalutamide

AK Seitz, S Thoene, A Bietenbeck, R Nawroth… - European urology, 2017 - Elsevier
Background It has been demonstrated that androgen receptor splice variant 7 (AR-V7)
expression in circulating tumor cells (CTCs) predicts poor treatment response in metastatic …
被引用次数：104 相关文章 所有 6 个版本
[HTML] sciencedirect.com

[HTML][HTML] Serial blood-based analysis of AR-V7 in men with advanced prostate cancer

M Nakazawa, C Lu, Y Chen, CJ Paller, MA Carducci… - Annals of …, 2015 - Elsevier
Background We previously showed that pretreatment detection of androgen receptor splice
variant-7 (AR-V7) in circulating tumor cells (CTCs) from men with castration-resistant …
被引用次数：185 相关文章 所有 9 个版本